In-depth pieces from our trial team on Monsanto's defective product, the science behind the IARC classification, who qualifies for a Roundup lawsuit, and what makes our strict-product-liability approach different. Written by Alex Alvarez, Board Certified Civil Trial Lawyer, and Herb Borroto, M.D., J.D.
Professional landscapers and institutional groundskeepers had some of the highest occupational glyphosate exposure. What makes their cases distinctive.
DLBCL is the most common NHL in the U.S. and one of the cancers most strongly linked to glyphosate. What treatment looks like and how DLBCL cases get built.
What bellwethers are, what the Roundup bellwether record has demonstrated, and what the results mean for plaintiffs considering a case now.
Agricultural pesticide applicators had the highest documented exposures. The Agricultural Health Study, the Worker Protection Standard, and what makes farmworker cases distinctive.
How multi-product exposure histories affect cases. The post-2000 generic glyphosate market and what plaintiffs with mixed-product histories should know.
Non-Hodgkin Lymphoma is more than 60 distinct subtypes. DLBCL, Follicular, Mantle Cell, Marginal Zone, CLL/SLL — a plain-English map of which ones fit the science.
Non-Hodgkin Lymphoma gets the headlines. Multiple Myeloma is the underclaimed Roundup cancer — especially among farmers, groundskeepers, and commercial applicators. What the science shows and who qualifies.
What internal Monsanto documents reveal about ghost-writing, attacks on IARC, and how we use them to build cases.
Yes — new cases are still being filed. What Bayer's $10.9B settlement did and didn't resolve, and the statute-of-limitations clock you cannot let run out.
The World Health Organization's IARC calls glyphosate a probable carcinogen. The EPA does not. The reason matters in court.
Two roads to the same defendant. One is harder for Monsanto to escape. The same theory we used to win $100M+ from Big Tobacco.
Three exposure categories, four qualifying cancers, and what we need to evaluate your case — whether you sprayed the back forty or the back yard.
Free, confidential case review. Herb Borroto, M.D., J.D., reads your pathology personally. No fees unless we recover for you.
